Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,945 | -3,638 | -1,436 | -3,330 |
| Accounts payable and accrued liabilities | 30 | 129 | 91 | N/A |
| Other Working Capital | 217 | 428 | 168 | 549 |
| Other Operating Activity | 723 | 539 | -6 | 0 |
| Operating Cash Flow | $-4,975 | $-2,542 | $-1,183 | $-2,781 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | 2,500 | N/A | N/A | N/A |
| Common Stock Issued | 5 | N/A | N/A | N/A |
| Other Financing Activity | 6,413 | 0 | 0 | 2,500 |
| Financing Cash Flow | $8,918 | $N/A | $N/A | $2,500 |
| Beginning Cash Position | 3,514 | 3,514 | 3,514 | 3,795 |
| End Cash Position | 7,457 | 97 | 2,331 | 3,514 |
| Net Cash Flow | $3,943 | $-2,542 | $-1,183 | $-281 |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,975 | -2,542 | -1,183 | -2,781 |
| Free Cash Flow | -4,975 | -2,542 | -1,183 | -2,781 |